1. Estimating the Growth Rate of Lung Metastases in Differentiated Thyroid Carcinoma: Response Evaluation Criteria in Solid Tumors or Doubling Time?
   Eyun Song et al, 2020, Thyroid CrossRef
2. Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer
   N. Reed et al, 2020, Clinical Oncology CrossRef
3. Normalization of Tumor Vessels by Lenvatinib‐Based Metallo‐Nanodrugs Alleviates Hypoxia and Enhances Calreticulin‐Mediated Immune Responses in Orthotopic HCC and Organoids
   Da Zhang et al, 2023, Small CrossRef
4. Lenvatinib Long-Term Responses in Refractory Thyroid Cancer: Our Mono-Institutional Real-Life Experience with the Multidisciplinary Approach and Review of Literature
   Nerina Denaro et al, 2019, Oncology CrossRef
5. Lenvatinib
   Koichi Suyama et al, 2018, Cancer Control CrossRef
6. Lenvatinib administration for elderly patients （over 80 years old） with advanced thyroid cancer
   Hiroyuki Ozawa et al, 2018, Toukeibu Gan CrossRef